| Erasca, Inc. | 12.2M | US$223M | 9.6% |
| Abivax Sa | 1.02M | US$136M | 5.9% |
| Revolution Medicines, Inc. | 700K | US$131M | 5.6% |
| Ideaya Biosciences, Inc. | 3M | US$112M | 4.8% |
| Vera Therapeutics, Inc. | 2.2M | US$94.4M | 4.1% |
| Tango Therapeutics, Inc. | 2.85M | US$89.1M | 3.8% |
| Praxis Precision Medicines, Inc. | 260K | US$87M | 3.7% |
| Celldex Therapeutics, Inc. | 2.1M | US$78.1M | 3.4% |
| Dianthus Therapeutics, Inc. | 800K | US$78M | 3.4% |
| Cg Oncology, Inc. | 1M | US$71M | 3.1% |
| Disc Medicine, Inc. | 875K | US$64M | 2.8% |
| Maze Therapeutics, Inc. | 1.94M | US$57.7M | 2.5% |
| Dyne Therapeutics, Inc. | 2.55M | US$56.6M | 2.4% |
| Ocular Therapeutix, Inc. | 5.3M | US$52M | 2.2% |
| Design Therapeutics, Inc. | 3M | US$43.4M | 1.9% |
| Olema Pharmaceuticals, Inc. | 3.21M | US$40.1M | 1.7% |
| Achieve Life Sciences, Inc. | 5.42M | US$35.4M | 1.5% |
| Trevi Therapeutics, Inc. | 1.88M | US$35.1M | 1.5% |
| Cogent Biosciences, Inc. | 900K | US$34.8M | 1.5% |
| Arrivent Biopharma, Inc. | 1M | US$34.7M | 1.5% |
| Crescent Biopharma, Inc. | 1.9M | US$34.2M | 1.5% |
| Mineralys Therapeutics, Inc. | 1.05M | US$28.3M | 1.2% |
| Replimune Group, Inc. | 2.5M | US$27.7M | 1.2% |
| Xenon Pharmaceuticals Inc. | 450K | US$27.2M | 1.2% |
| Immunovant, Inc. | 665K | US$25.6M | 1.1% |
| Jade Biosciences, Inc. | 1.13M | US$25M | 1.1% |
| Enliven Therapeutics, Inc. | 465K | US$23.6M | 1.0% |
| Veradermics, Incorporated | 180K | US$22.1M | 0.95% |
| Avalo Therapeutics, Inc. | 1.15M | US$21.3M | 0.91% |
| Arcus Biosciences, Inc. | 650K | US$20M | 0.86% |
| Summit Therapeutics Inc. | 1.35M | US$19.7M | 0.85% |
| Lb Pharmaceuticals Inc | 585K | US$19M | 0.82% |
| Minerva Neurosciences, Inc | 3.29M | US$18.3M | 0.79% |
| Sensei Biotherapeutics, Inc. | 722K | US$18.1M | 0.78% |
| Dbv Technologies Sa | 915K | US$15M | 0.65% |
| Parabilis Medicines, Inc. | 525K | US$14.4M | 0.62% |
| Rhythm Pharmaceuticals, Inc. | 125K | US$13.9M | 0.60% |
| Vor Biopharma Inc. | 650K | US$12M | 0.52% |
| Scholar Rock Holding Corporation | 200K | US$11M | 0.47% |
| Immix Biopharma, Inc. | 1M | US$10.3M | 0.44% |
| Q32 Bio Inc. | 800K | US$10.2M | 0.44% |
| Odyssey Therapeutics, Inc. | 522K | US$9.76M | 0.42% |
| Annexon, Inc. | 1.5M | US$8.56M | 0.37% |
| Editas Medicine, Inc. | 2.22M | US$7.2M | 0.31% |
| Relay Therapeutics, Inc. | 350K | US$6.55M | 0.28% |
| Acadia Pharmaceuticals Inc. | 250K | US$6.33M | 0.27% |
| Amylyx Pharmaceuticals, Inc. | 350K | US$6.29M | 0.27% |
| Cybin, Inc. | 750K | US$4.96M | 0.21% |
| Onkure Therapeutics, Inc. | 964K | US$4.4M | 0.19% |
| Tenax Therapeutics, Inc. | 300K | US$4.37M | 0.19% |
| Definium Therapeutics, Inc. | 80,000 | US$3.76M | 0.16% |
| Unicycive Therapeutics, Inc. | 474K | US$2.22M | 0.10% |
| Palatin Technologies, Inc. | 130K | US$1.4M | 0.06% |
| Jatt Ii Acquisition Corp | 100K | US$1.14M | 0.05% |
| Research Alliance Corporation Iii | 100K | US$1.07M | 0.05% |
| Aclaris Therapeutics, Inc. | 200K | US$1.06M | 0.05% |
| Longeveron Inc. | 1.29M | US$905K | 0.04% |
| Fractyl Health, Inc. | 1M | US$794K | 0.03% |
| Septerna, Inc. | 23,548 | US$789K | 0.03% |
| Amanat Acquisition Corp | 50,000 | US$508K | 0.02% |
| Mirum Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Oric Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
| United Therapeutics Corporation | 0 | US$0 | 0.00% |
| Vaxcyte, Inc. | 0 | US$0 | 0.00% |
| Verastem, Inc. | 0 | US$0 | 0.00% |
| Biogen Inc. | 0 | US$0 | 0.00% |
| Compass Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Corvus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Cytokinetics, Incorporated | 0 | US$0 | 0.00% |
| Ibio, Inc. | 0 | US$0 | 0.00% |
| Janux Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Madrigal Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Meiragtx Holdings Plc | 0 | US$0 | 0.00% |